Mark S. Plummer

An analysis of FDA-approved drugs for infectious disease: antibacterial agents

Michael S. Kinch, Eric Patridge, Mark S. Plummer et al. · Drug Discovery Today · 2014 · 118 citations

Pharmacy, Infectious Diseases, Pharmacology +16

Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora

Ken Blount, Cynthia M. Megyola, Mark S. Plummer et al. · Antimicrobial Agents and Chemotherapy · 2015 · 100 citations · Full text

Medicine, Microbiology, Pharmacology +13

Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections

Matthew F. Brown, Usa Reilly, J. A. Abramite et al. · Journal of Medicinal Chemistry · 2011 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections

Justin I. Montgomery, Matthew F. Brown, Usa Reilly et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Cation-stabilizing auxiliaries in polyene cyclizations. 7. The fluorine atom as a cation-stabilizing auxiliary in biomimetic polyene cyclizations. 4. Total synthesis of dl-.beta.-amyrin.

William S. Johnson, Mark S. Plummer, Santhi Reddy et al. · Journal of the American Chemical Society · 1993 · 92 citations

Natural Sciences, Chemistry, Organic Chemistry +8